It's like rocket science…only more complex: challenges and experiences related to managing pediatric obesity in

Jillian Ls Avis1, Tracey Bridger2,3, Annick Buchholz4

  • 1a Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T5K0L4, Canada.

Insights

Canadian pediatric obesity affects one-third of children, necessitating effective services. This review addresses challenges in managing childhood obesity, focusing on family care, professional collaboration, and healthcare system improvements.

Area of Science:

  • Public Health
  • Pediatrics
  • Obesity Management

Background:

  • Pediatric obesity is a significant public health concern in Canada, affecting approximately one-third of children.
  • Overweight and obesity in children increase risks for short- and long-term health issues.
  • Effective and accessible services are crucial for managing pediatric obesity.

Purpose of the Study:

  • To review common challenges encountered in pediatric obesity management.
  • To share real-world experiences from clinical and research centers.
  • To identify lessons learned and ongoing initiatives for optimizing care.

Main Methods:

  • The review synthesizes experiences from clinical and research settings.
  • Challenges are categorized into three main areas: family care, professional collaboration, and healthcare system integration.
  • Lessons learned and current initiatives are highlighted.

Main Results:

  • Common challenges in pediatric obesity management span family-centered care, interprofessional collaboration, and healthcare system navigation.
  • Real-world experiences offer insights into practical difficulties and potential solutions.
  • Ongoing initiatives aim to enhance service delivery for pediatric obesity.

Conclusions:

  • Addressing pediatric obesity requires a multi-faceted approach considering families, healthcare professionals, and the broader system.
  • Sharing experiences and lessons learned is vital for improving obesity management strategies.
  • Optimizing health services is essential to mitigate the impact of childhood obesity in Canada.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Physical Growth During Infancy and Toddlerhood01:18

Physical Growth During Infancy and Toddlerhood

Physical growth is especially rapid during the first three years of life, with the greatest rate in the first few months after birth. Although children continue to gain height and weight throughout infancy and toddlerhood, the rate of growth gradually slows during the second and third years. At most ages, boys are typically slightly taller and heavier than girls, reflecting a common pattern of early physical development.Changes in Body ProportionsAs infants become toddlers, their body...